Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years

Clinical trial NCT04895982 · COMPLETED

Trial details

NCT number: NCT04895982
Sponsor: BioNTech SE
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

SARS-CoV-2 Infection, COVID19

Start date: 2021-10-15
Primary completion: 2023-07-23
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.